Duopharma Biotech invests RM2.06mil in local digital service provider


  • Business
  • Wednesday, 09 Jun 2021

KUALA LUMPUR: Duopharma Biotech Bhd will invest US$500,000 (RM2.06mil) in a local digital health service provider via a Series A funding round to expand its smart digital integrated health applications.

The investment in Naluri Hidup Sdn Bhd, which is a local pioneer in digital therapeutics, follows Duopharma's initial investment of US$250,000 in the company for a personalised digital holistic healthcare application.

Duopharma said in a statement that its investment along with that of other international and local venture capital firms, will enable Naluri to expand operations into the region and deepen its data science capabilities.

It added that the partnership will enable it to deliver evidence-based therapeutic interventions using Naluri's digital therapeutics solution, which is designed to help people manage their chronic disease risks through structured multi-disciplinary behavioural and psychological coaching programmes.

According to Duopharma, effective use of holistic therapeutics could double the healthcare effectiveness when compared to a purely pharmacotherapeutic (medication

only) approach, and could also be four times more cost-efficient and increase accessibility to clinicians and other health and fitness experts online as well.

"The smart application of digital technologies to enhance the effectiveness of healthcare and achieve the objective of a healthier life for all is one of Duopharma Biotech's strategic pillars.

"We are proud to be part of this latest milestone to empower homegrown health technologies," said Duopharma group managing director Leonard Ariff Abdul Shatar.
Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

   

Next In Business News

Cagamas concludes issuance of RM1.09bil bonds, sukuk
Bursa Malaysia aims for 300 PLCs to participate in transformation programme by 2025
Oil prices climb after Opec+ keeps output cut targets, China eases Covid curbs
Chinese snack maker Weilong Delicious aims to raise up to US$141mil in trimmed-down Hong Kong IPO
Yuan jumps past 7 per dollar as China eases some Covid curbs
Foxconn expects Covid-hit�China plant�back to full output in late Dec-early Jan�-source
Mestron secures RM10mil order from Singapore's Tamaco
FBM KLCI remains on a slide while region picks up on China's easing lockdown
Bursa Malaysia emphasises digitalisation, nation building for PLCs
TNB calls for global collaboration in journey towards a sustainable future

Others Also Read